Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Amid back office consolidation, Gilead axes 179 jobs in California
Endpoints
Thu, 03/4/21 - 10:02 am
Gilead Sciences
California
North Carolina
RTP
layoffs
While Life Sciences Industry Remains Strong, Some Big Names Face Layoffs
BioSpace
Tue, 03/2/21 - 12:15 pm
COVID-19
pandemic
layoffs
Gilead Sciences
Amgen
GSK
Sanofi
Viatris
Gilead's $5B Galapagos black hole widens as pair toss out phase 3 asset after flop
Fierce Biotech
Wed, 02/10/21 - 10:29 am
Gilead Sciences
Galapagos
IPF
ziritaxestat
Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rivalrnings season continues to show COVID-19 uncertainty
Fierce Pharma
Mon, 02/8/21 - 10:38 pm
TG Therapeutics
FDA
Ukoniq
umbralisib
follicular lymphoma
marginal zone lymphoma
Gilead Sciences
'Can't say no': Kite Pharma taps Frank Neumann as new head of clinical development
Endpoints
Mon, 02/8/21 - 10:33 am
Kite Pharma
Gilead Sciences
clinical development
Veklury rescues Gilead from COVID doldrums in Q4
Pharmaforum
Fri, 02/5/21 - 10:44 am
Gilead Sciences
Veklury
earnings
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
BioPharma Dive
Mon, 02/1/21 - 10:48 am
Gilead Sciences
HIV
Gritstone Oncology
drug development
Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers
KHN
Wed, 01/27/21 - 08:07 pm
Gilead Sciences
remdesivir
COVID-19
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
Sun, 01/24/21 - 03:24 pm
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
Gilead says Veklury should work against COVID-19 variants
Pharmaforum
Fri, 01/22/21 - 10:42 am
Gilead Sciences
Veklury
remdesivir
B.1.1.7 variant
After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO
Fierce Biotech
Thu, 01/21/21 - 10:32 am
NexImmune
Gilead Sciences
Kite Pharma
IPOs
Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead
Fierce Pharma
Tue, 01/19/21 - 09:18 pm
Merck
Idenis
Gilead Sciences
patents
Harvoni
Sovaldi
Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA
Fierce Biotech
Tue, 01/19/21 - 10:38 am
Vera Therapeutics
Merck KGaA
clinical trials
kidney disease
atacicept
Gilead Sciences
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike
BioSpace
Wed, 01/13/21 - 12:07 am
Gilead Sciences
COVID-19
remdesivir
Veklury
Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus
NASDAQ
Tue, 01/12/21 - 11:01 am
Gilead Sciences
Vir Biotechnology
hepatitis B
clinical trials
Oxford BioTherapeutics to research cell therapies for Gilead’s Kite
Pharmaforum
Thu, 01/7/21 - 11:28 am
Kite Pharma
Gilead Sciences
Oxford BioTherapeutics
solid tumors
blood cancer
cell therapy
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Fierce Pharma
Mon, 01/4/21 - 11:04 pm
drug pricing
Pfizer
AbbVie
Teva Pharmaceutical
Sanofi
Gilead Sciences
Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?
Fierce Biotech
Sun, 01/3/21 - 04:29 pm
China
COVID-19
Gilead Sciences
remdesivir
Folotyn
Acrotech Biopharma
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »